Richard Chang John A Butman Russell R Lonser Richard M Sherry Prakash K Pandalai McDonald K Horne 3rd Jay N Lozier
10.1016/j.jvir.2012.09.017
J Vasc Interv Radiol
2013 Jan;24(1):27-34.e1.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/23273695/
Anticoagulants / administration & dosage Tissue Plasminogen Activator / administration & dosage Venous Thrombosis / drug therapy
Anticoagulants / administration & dosage Tissue Plasminogen Activator / administration & dosage Venous Thrombosis / drug therapy Case Reports Research Support, N.I.H., Extramural Adult Aged Aged, 80 and over Dose-Response Relationship, Drug Drug Therapy, Combination / methods Female Fibrinolytic Agents / administration & dosage Humans Male Middle Aged Recombinant Proteins / administration & dosage Tissue Plasminogen Activator / genetics Treatment Outcome Anticoagulants Fibrinolytic Agents Recombinant Proteins Tissue Plasminogen Activator
PMC3636547
23273695
Treatment of high-risk venous thrombosis patients using low-dose intraclot injections of recombinant tissue plasminogen activator and regional anticoagulation
2013